Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment.
about
Viral entry pathways: the example of common cold virusesViral quasispecies evolutionInsights into minor group rhinovirus uncoating: the X-ray structure of the HRV2 empty capsidMolecular mechanism of SCARB2-mediated attachment and uncoating of EV71The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor bindingHuman rhinovirus type 54 infection via heparan sulfate is less efficient and strictly dependent on low endosomal pH.Symmetry-related clustering of positive charges is a common mechanism for heparan sulfate binding in enteroviruses.Single Neutralizing Monoclonal Antibodies Targeting the VP1 GH Loop of Enterovirus 71 Inhibit both Virus Attachment and Internalization during Viral EntryInteractions between multiple genetic determinants in the 5' UTR and VP1 capsid control pathogenesis of chronic post-viral myopathy caused by coxsackievirus B1Virus entry paradigms.The cell biology of receptor-mediated virus entry.Clinical and molecular features of human rhinovirus C.Roles of cellular activation and sulfated glycans in Haemophilus somnus adherence to bovine brain microvascular endothelial cells.Mutations in VP1 and 3A proteins improve binding and replication of rhinovirus C15 in HeLa-E8 cells.Rhinoviruses and Their Receptors: Implications for Allergic DiseaseThe Unresolved Role of Interferon-λ in Asthma Bronchiale.Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor.Intracellular trafficking and fate of chimeric adenovirus 5/F35 in human B lymphocytes.Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection.Coxsackievirus A16 utilizes cell surface heparan sulfate glycosaminoglycans as its attachment receptor.N- and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells.Productive entry pathways of human rhinoviruses.
P2860
Q26750146-5069A358-BE90-4853-9722-2E59B0D3A805Q27013917-0143783B-008F-4537-9251-7ABBFA96E0E1Q27347786-2C2D2E54-E325-4065-9DE0-6A52A89B584CQ27684518-62C45BCA-912A-4A78-B860-4F9BCF9F37C2Q33842994-237CF80C-F396-4B1F-A3CF-8840E1BE87EAQ35857392-13317D75-CFDA-4F43-A455-A04D8CB6EB08Q36276298-F6A240B0-F6C3-4EB9-A8EF-B66780D4A7D6Q36281127-03B1531F-6D3C-4FD7-8C88-2DC621A046F8Q36600425-8607034B-9879-4AF3-8F65-ED461E8246FAQ37614299-25F94447-CAA7-443F-AE21-26EDFE27677CQ37962258-C3137F80-3EA0-4793-A0E0-0988472891B0Q37979613-B7C48C5D-7536-4989-A4B9-C11217B8A4C0Q38482939-77B18D33-3619-4542-BF83-33E39C70020EQ38741130-45FA8F92-4ABE-4178-89A1-40A23677EDEDQ38767263-988265F8-B085-4A70-BEC4-B430D3DD6F9AQ39190363-A0206DEB-B815-45E6-9F01-F11FFC56CA47Q39253638-60A39B53-7DF2-4AC7-A4EE-00A8A73A9BF6Q39505173-DB6558EF-6B53-4F8D-8427-71E54E0ADB34Q40039908-43EE5E67-67F5-428C-ADE0-C923D7B2E937Q40107981-2E1A32C8-B823-42CF-9878-19931D0202D5Q41497346-53978F57-5776-47B2-AE32-C795FA5436F9Q42090065-7BC97B7D-9AA1-4D59-AA50-FB174BE32326
P2860
Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment.
@en
type
label
Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment.
@en
prefLabel
Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment.
@en
P2093
P2860
P1433
P1476
Human rhinovirus type 89 variants use heparan sulfate proteoglycan for cell attachment.
@en
P2093
Dieter Blaas
Irene Goesler
Markete Vlasak
P2860
P304
P356
10.1128/JVI.79.10.5963-5970.2005
P407
P577
2005-05-01T00:00:00Z